Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-14

Clinical Trial Update: Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets [Phase 1]

View source ↗

Summary

This Phase 1 bioavailability study evaluates oral OZ439 prototype granule formulations co-administered with Piperaquine phosphate tablets; results were posted a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZ439
  • Piperaquine Phosphate (piperaquine phosphate)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2016-01-14